VBI Vaccines Inc.
VBIV · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $9,149 | $100,720 | $596,576 | $600,240 |
| - Cash | $23,685 | $62,629 | $121,694 | $93,825 |
| + Debt | $53,040 | $52,225 | $31,796 | $944 |
| Enterprise Value | $38,504 | $90,316 | $506,678 | $507,359 |
| Revenue | $8,682 | $1,082 | $631 | $1,061 |
| % Growth | 702.4% | 71.5% | -40.5% | – |
| Gross Profit | -$5,815 | -$10,194 | -$10,139 | -$8,107 |
| % Margin | -67% | -942.1% | -1,606.8% | -764.1% |
| EBITDA | -$82,782 | -$106,020 | -$62,814 | -$41,257 |
| % Margin | -953.5% | -9,798.5% | -9,954.7% | -3,888.5% |
| Net Income | -$92,836 | -$140,951 | -$72,650 | -$47,286 |
| % Margin | -1,069.3% | -13,026.9% | -11,513.5% | -4,456.7% |
| EPS Diluted | -5.96 | -16.37 | -8.55 | -6.5 |
| % Growth | 63.6% | -91.5% | -31.5% | – |
| Operating Cash Flow | -$60,883 | -$73,695 | -$39,908 | -$47,050 |
| Capital Expenditures | -$867 | -$4,344 | -$1,995 | -$1,000 |
| Free Cash Flow | -$61,750 | -$78,039 | -$41,903 | -$48,050 |